In neuroendocrine tumor cells, the signal transducer and activator of the transcription 3 (STAT3)/IL-6 axis has been implicated in proliferation, survival, and differentiation through MAPK-dependent signaling. This evidence concerns the gene STAT3 and neuroendocrine neoplasm.